Prediction and Analysis of COVID-19 Epidemic Based on Improved GEP Algorithm to Optimize SEIR Mode

In 2019, COVID-19 (CoronaVirus Disease 2019) broke out all over the world. COVID-19 is an infectious disease, which has a huge impact on the global economy. It is very difficult to prevent and control the epidemic situation of this infectious disease. At present, many SEIR(Susceptible Exposed Infected Recovered)models are used to predict the number of infectious diseases, which has the shortcomings of low prediction accuracy and inaccurate inflection point prediction. Therefore, this paper proposes that the prediction and analysis of COVID-19 based on improved GEP algorithm and optimized SEIR model can improve the prediction accuracy and inflection point prediction accuracy, and provide a theoretical basis for epidemic prevention of large-scale infectious diseases in the future. The algorithm. First, establish SEIR (Susceptible Exposed Infected Recovered) model to analyze the epidemic trend, and then use improved GEP (Gene Expression Programming) algorithm to analyze the infection coefficient of SEIR model beta And coefficient of restitution y, perform parameter estimation to optimize the initial value I and recovery coefficient of the infected population y and so on to improve the accuracy of model prediction. The experimental data take the number of COVID-19 infected people in the United States, China, the United Kingdom and Italy as examples. The results show that the SEIR model optimized based on the improved GEP algorithm conforms to the inflection point of the actual data, and the average error value is 1.32%. The algorithm provides a theoretical basis for the future epidemic prevention. © 2022 IEEE.

Prediction on transmission trajectory of COVID-19 based on particle swarm algorithm.

This study aimed to predict the transmission trajectory of the 2019 Corona Virus Disease (COVID-19). The particle swarm optimization (PSO) algorithm was combined with the traditional susceptible exposed infected recovered (SEIR) infectious disease prediction model to propose a SEIR-PSO prediction model on the COVID-19. In addition, the domestic epidemic data from February 25, 2020 to March 20, 2020 in China were selected as the training set for analysis. The results showed that when the conversion rate, recovery rate, and mortality rate of the SEIR-PSO model were 1/5, 1/15, and 1/13, its predictive effect on the number of people diagnosed with COVID-19 was the closest to the real data; and the SEIR-PSO model showed a mean-square errors (MSE) value of 1304.35 and mean absolute error (MAE) value of 1069.18, showing the best prediction effect compared with the susceptible infectious susceptible (SIS) model and the SEIR model. In contrary to the standard particle swarm optimization (SPSO) and linear weighted particle swarm optimization (LPSO), which were two classical improved PSO algorithms, the reliability and diversity of the SEIR-PSO model were higher. In summary, the SEIR-PSO model showed excellent performance in predicting the time series of COVID-19 epidemic data, and showed reliable application value for the prevention and control of COVID-19 epidemic.

Effect evaluation of non-pharmaceutical interventions taken in China to contain the COVID-19 epidemic based on the susceptible-exposed-infected-recovered model.

This paper takes confirmed cases of COVID-19 from January 20 to March 18, 2020 as the sample set to establish the susceptible-exposed-infected-recovered (SEIR) model. By evaluating effects of different non-pharmaceutical interventions (NPIs), the research expects to provide references to other countries for formulating corresponding policies. This article divides all non-pharmaceutical interventions into three types according to their different roles. The results show that type-A and type-B non-pharmaceutical interventions both can delay the timing of large-scale infections of the susceptible population, timing of the number of exposed individuals to peak, and timing of peaking of the number of infected cases, as well as decrease the peak number of exposed cases. Moreover, type-B non-pharmaceutical interventions have more significant effects on susceptible and exposed populations. Type-C non-pharmaceutical interventions for improving the recovery rate of patients are able to effectively reduce the peak number of patients, greatly decrease the slope of the curve for the number of infected cases, substantially improve the recovery rate, and lower the mortality rate; however, these non-pharmaceutical interventions do not greatly delay the timing of the number of infected cases to peak. And based on the above analysis, we proposed some suggestions.